Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | TDO2 | P48775 | 2/20 | 0.32 |
| ▸ | GSK3B | P49841 | 2/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.30 |
| ▸ | CDC7 | O00311 | 1/20 | 0.30 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.30 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29293165 | 0.86 | PDK2 (0.43) | PDK2BACE1BACE2PDE10ACYP17A1 | |
| SCHEMBL29293167 | 0.85 | PDK2 (0.44) | PDK2BACE1BACE2PDE10ACYP17A1 | |
| SCHEMBL10018865 | 0.83 | MLNR (0.36) | PDK2ALOX5LIMK1 | |
| SCHEMBL29293047 | 0.82 | PDK2 (0.43) | PDK2BACE1PDE10ACYP17A1CYP1A2 | |
| SCHEMBL29293143 | 0.78 | NOTUM (0.47) | PDE10ACYP17A1CYP1A2MAPK11MAPK14 | |
| SCHEMBL23770422 | 0.78 | ALOX5 (0.38) | PDK2BACE1BACE2PDE10AALOX5 | |
| SCHEMBL19271478 | 0.78 | LIMK1 (0.35) | PDK2LIMK1 | |
| SCHEMBL23770491 | 0.78 | ALOX5 (0.39) | BACE1BACE2PDE10AALOX5 | |
| SCHEMBL17563654 | 0.75 | TDO2 (0.37) | BACE1BACE2PDE10ACYP17A1CYP1A2 | |
| SCHEMBL17211270 | 0.75 | LIMK1 (0.33) | LIMK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | P&H TECH CO., LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | P&H TECH CO., LTD (KR) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228470-A1 | Organic Compound And Organic Light Emitting Device Including Same | OR10J3, ORMDL3, OR51E2 | PDK2 2309/4885BACE1 1713/4885BACE2 1932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.